Javascript must be enabled to continue!
Dysregulated Protease Homeostasis Defines Primary FSGS
View through CrossRef
Key Points
Serum proteomics reveals reduced serpin family A member 1 (
SERPINA1
) in primary FSGS, distinguishing it from other proteinuric kidney diseases.
Serpina1
knockdown in zebrafish causes proteinuria and edema, supporting its functional relevance in glomerular disease.
SERPINA1
may exert compartment-specific functions, and its decrease may permit protease activity to contribute to podocyte injury in primary FSGS.
Background
Primary FSGS (pFSGS) is caused by circulating permeability factors. Despite extensive efforts, no single causative factor or biomarker signature has been identified that reliably predicts disease or therapeutic outcomes across all patients. By using liquid chromatography-mass spectrometry–based proteomics on serum samples from patients with pFSGS, compared with controls, we aimed to identify disease-specific protein signatures.
Methods
Liquid chromatography-mass spectrometry–based proteomics analysis was performed on 103 serum samples from 36 patients with pFSGS, 33 patients with other proteinuric diseases, and 34 healthy controls. Selected proteins found to be dysregulated in pFSGS were tested in cell culture experiments in immortalized human podocytes. Knockdown experiments were performed in zebrafish larvae, which were screened for proteinuria, edema, and podocyte marker expression. Immunofluorescent staining on zebrafish sections and patients' kidney biopsies was used to confirm findings.
Results
Mass spectrometry of sera from patients revealed a set of 27 proteins specifically affected in pFSGS, including a dysbalance of proteases and protease inhibitors. A subset of younger pFSGS patients with frequent relapses showed a distinct serum protein profile based on 23 dysregulated proteins. From proteomics results, serpin family A member 1 (
SERPINA1
;
α
-1-antitrypsin) was selected for further investigations. Urinary
SERPINA1
increased across nephrotic syndromes, whereas serum
SERPINA1
reduction was specific to pFSGS, suggesting a distinct underlying pathophysiology involving immune modulation, increased protease activity, or systemic depletion. Glomerular
SERPINA1
expression was selectively increased in sclerotic lesions, likely reflecting a local compensatory response to protease stress. Podocytes constitutively secreted
SERPINA1
, with limited adaptive response under protease stress. Finally, systemic
Serpina1
knockdown in zebrafish induced edema, proteinuria, and loss of slit diaphragm markers.
Conclusions
Our findings support a causal and compartment-specific role of
SERPINA1
and suggest that reduced circulating protease inhibitors may shift the local protease-antiprotease balance, potentially facilitating podocyte injury in pFSGS.
Ovid Technologies (Wolters Kluwer Health)
Title: Dysregulated Protease Homeostasis Defines Primary FSGS
Description:
Key Points
Serum proteomics reveals reduced serpin family A member 1 (
SERPINA1
) in primary FSGS, distinguishing it from other proteinuric kidney diseases.
Serpina1
knockdown in zebrafish causes proteinuria and edema, supporting its functional relevance in glomerular disease.
SERPINA1
may exert compartment-specific functions, and its decrease may permit protease activity to contribute to podocyte injury in primary FSGS.
Background
Primary FSGS (pFSGS) is caused by circulating permeability factors.
Despite extensive efforts, no single causative factor or biomarker signature has been identified that reliably predicts disease or therapeutic outcomes across all patients.
By using liquid chromatography-mass spectrometry–based proteomics on serum samples from patients with pFSGS, compared with controls, we aimed to identify disease-specific protein signatures.
Methods
Liquid chromatography-mass spectrometry–based proteomics analysis was performed on 103 serum samples from 36 patients with pFSGS, 33 patients with other proteinuric diseases, and 34 healthy controls.
Selected proteins found to be dysregulated in pFSGS were tested in cell culture experiments in immortalized human podocytes.
Knockdown experiments were performed in zebrafish larvae, which were screened for proteinuria, edema, and podocyte marker expression.
Immunofluorescent staining on zebrafish sections and patients' kidney biopsies was used to confirm findings.
Results
Mass spectrometry of sera from patients revealed a set of 27 proteins specifically affected in pFSGS, including a dysbalance of proteases and protease inhibitors.
A subset of younger pFSGS patients with frequent relapses showed a distinct serum protein profile based on 23 dysregulated proteins.
From proteomics results, serpin family A member 1 (
SERPINA1
;
α
-1-antitrypsin) was selected for further investigations.
Urinary
SERPINA1
increased across nephrotic syndromes, whereas serum
SERPINA1
reduction was specific to pFSGS, suggesting a distinct underlying pathophysiology involving immune modulation, increased protease activity, or systemic depletion.
Glomerular
SERPINA1
expression was selectively increased in sclerotic lesions, likely reflecting a local compensatory response to protease stress.
Podocytes constitutively secreted
SERPINA1
, with limited adaptive response under protease stress.
Finally, systemic
Serpina1
knockdown in zebrafish induced edema, proteinuria, and loss of slit diaphragm markers.
Conclusions
Our findings support a causal and compartment-specific role of
SERPINA1
and suggest that reduced circulating protease inhibitors may shift the local protease-antiprotease balance, potentially facilitating podocyte injury in pFSGS.
Related Results
Clinicopathological Outcomes in Focal Segmental Glomerulosclerosis: A Retrospective Cohort Study
Clinicopathological Outcomes in Focal Segmental Glomerulosclerosis: A Retrospective Cohort Study
Introduction: Focal Segmental Glomerulosclerosis (FSGS) is a nephrotic syndrome with a variety of clinicopathological presentations and varied responses to treatment. Hence, this s...
MO247NOVEL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES REVEAL CHANGED METABOLOMIC PROFILE IN RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS*
MO247NOVEL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES REVEAL CHANGED METABOLOMIC PROFILE IN RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS*
Abstract
Background and Aims
Idiopathic forms of Focal Segmental Glomerulosclerosis (FSGS) are caused by circulating permeabilit...
The role of HLA antigens in recurrent primary focal segmental glomerulosclerosis
The role of HLA antigens in recurrent primary focal segmental glomerulosclerosis
Primary focal segmental glomerulosclerosis (FSGS), typically characterized by diffuse podocyte foot process effacement and nephrotic syndrome (diffuse podocytopathy), is generally ...
Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis
Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis
Abstract
Idiopathic forms of Focal Segmental Glomerulosclerosis (FSGS) are caused by circulating permeability factors, which can lead to early recurrence of FSGS ...
Novel Diagnostic and Therapeutic Techniques Reveal Changed Metabolic Profiles in Recurrent Focal Segmental Glomerulosclerosis
Novel Diagnostic and Therapeutic Techniques Reveal Changed Metabolic Profiles in Recurrent Focal Segmental Glomerulosclerosis
Abstract
Idiopathic forms of Focal Segmental Glomerulosclerosis (FSGS) are caused by circulating permeability factors, which can lead early recurrence of FSGS and kidney fa...
Adult-Onset Genetic Focal Segmental Glomerulosclerosis: A Tale of Two Mutations
Adult-Onset Genetic Focal Segmental Glomerulosclerosis: A Tale of Two Mutations
Focal segmental glomerulosclerosis (FSGS) is a kidney histologic lesion that may be caused by multiple aetiologies and pathophysiological mechanisms, with podocyte injury and deple...
Value of urinary CD80 in differentiating minimal change disease from focal segmental glomerulosclerosis
Value of urinary CD80 in differentiating minimal change disease from focal segmental glomerulosclerosis
Background. Minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) are two common forms of childhood nephrotic syndrome (NS). Separating MCD from FSGS is essent...
Nephroprotective Effects of Curcumin in Murine Models of Focal and Segmental Glomerulosclerosis
Nephroprotective Effects of Curcumin in Murine Models of Focal and Segmental Glomerulosclerosis
Introduction: This study aims to explore the reno-protective effect of curcumin in focal and segmental glomerulosclerosis (FSGS) in murine models, a common chronic glomerulopathy t...

